BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Keebler D, Teng E, Chia J, Galanter J, Peake J, Tuckwell K. Regional variations in adverse event reporting rates and ACR responses in placebo/standard-of-care arms of rheumatoid arthritis trials. Rheumatology (Oxford) 2020;59:3023-31. [PMID: 32182362 DOI: 10.1093/rheumatology/keaa043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Combe B, Besuyen R, Gómez-Centeno A, Matsubara T, Sancho Jimenez JJ, Yin Z, Buch MH. Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis. Rheumatol Ther 2022. [PMID: 36205910 DOI: 10.1007/s40744-022-00494-1] [Reference Citation Analysis]
2 Oyebanji OA, Wilson B, Keresztesy D, Carias L, Wilk D, Payne M, Aung H, Denis KS, Lam EC, Rowley CF, Berry SD, Cameron CM, Cameron MJ, Schmader KE, Balazs AB, King CL, Canaday DH, Gravenstein S. Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents? Aging Clin Exp Res 2021;33:3151-60. [PMID: 34652783 DOI: 10.1007/s40520-021-01987-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
3 Ikemoto T, Ueno T, Arai YC, Wakao N, Hirasawa A, Hayashi K, Deie M. Open-Label Placebo Trial among Japanese Patients with Chronic Low Back Pain. Pain Res Manag 2020;2020:6636979. [PMID: 33425079 DOI: 10.1155/2020/6636979] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Cohen S, Tuckwell K, Katsumoto TR, Zhao R, Galanter J, Lee C, Rae J, Toth B, Ramamoorthi N, Hackney JA, Berman A, Damjanov N, Fedkov D, Jeka S, Chinn LW, Townsend MJ, Morimoto AM, Genovese MC. Fenebrutinib versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, Phase II Trial (ANDES Study). Arthritis Rheumatol 2020. [PMID: 32270926 DOI: 10.1002/art.41275] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 25.0] [Reference Citation Analysis]